Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manit Arya

Showing results (111-120 of 129) with videos related to

Pageof 13
Sort By:
Journal of Endourology|April 8, 2020
An Exploratory Study of Dose Escalation <i>vs</i> Standard Focal High-Intensity Focused Ultrasound for Treating Nonmetastatic Prostate CancerPhilipp M Huber, Naveed Afzal, Manit Arya, et al.
Cancer Research|June 22, 2016
CSN1 Somatic Mutations in Penile Squamous Cell CarcinomaAndrew Feber, Daniel C Worth, Ankur Chakravarthy, et al.
European Urology|July 2, 2018
A Multicentre Study of 5-year Outcomes Following Focal Therapy in Treating Clinically Significant Nonmetastatic Prostate CancerStephanie Guillaumier, Max Peters, Manit Arya, et al.
The Journal of Urology|November 23, 2016
The Effect of Dutasteride on Magnetic Resonance Imaging Defined Prostate Cancer: MAPPED-A Randomized, Placebo Controlled, Double-Blind Clinical TrialCaroline M Moore, Nicola L Robertson, Fatima Jichi, et al.
European Urology Oncology|August 15, 2019
A Multicentre Analysis of the Detection of Clinically Significant Prostate Cancer Following Transperineal Image-fusion Targeted and Nontargeted Systematic Prostate Biopsy in Men at RiskSaiful Miah, Feargus Hosking-Jervis, Martin J Connor, et al.
Journal of Medical Economics|September 1, 2023
Focal therapy versus radical prostatectomy and external beam radiotherapy as primary treatment options for non-metastatic prostate cancer: results of a cost-effectiveness analysisDeepika Reddy, Marieke van Son, Max Peters, et al.
The Prostate|August 4, 2018
Immunohistochemical biomarker validation in highly selective needle biopsy microarrays derived from mpMRI-characterized prostatesJonathan Olivier, Vasilis Stavrinides, Jonathan Kay, et al.
BMC Medical Imaging|November 16, 2019
Localising occult prostate cancer metastasis with advanced imaging techniques (LOCATE trial): a prospective cohort, observational diagnostic accuracy trial investigating whole-body magnetic resonance imaging in radio-recurrent prostate cancerSola Adeleke, Arash Latifoltojar, Harbir Sidhu, et al.
The Journal of Urology|April 4, 2023
Evaluation of Outcomes Following Focal Ablative Therapy for Treatment of Localized Clinically Significant Prostate Cancer in Patients >70 Years: A Multi-institute, Multi-energy 15-Year ExperienceDavid Habashy, Deepika Reddy, Max Peters, et al.
Prostate Cancer and Prostatic Diseases|May 2, 2021
Conventional radical versus focal treatment for localised prostate cancer: a propensity score weighted comparison of 6-year tumour controlMarieke J van Son, Max Peters, Deepika Reddy, et al.
Pageof 13

Showing results (111-120 of 129) with videos related to

Sort By:
Pageof 13
Journal of Endourology|April 8, 2020
An Exploratory Study of Dose Escalation <i>vs</i> Standard Focal High-Intensity Focused Ultrasound for Treating Nonmetastatic Prostate CancerPhilipp M Huber, Naveed Afzal, Manit Arya, et al.
Cancer Research|June 22, 2016
CSN1 Somatic Mutations in Penile Squamous Cell CarcinomaAndrew Feber, Daniel C Worth, Ankur Chakravarthy, et al.
European Urology|July 2, 2018
A Multicentre Study of 5-year Outcomes Following Focal Therapy in Treating Clinically Significant Nonmetastatic Prostate CancerStephanie Guillaumier, Max Peters, Manit Arya, et al.
The Journal of Urology|November 23, 2016
The Effect of Dutasteride on Magnetic Resonance Imaging Defined Prostate Cancer: MAPPED-A Randomized, Placebo Controlled, Double-Blind Clinical TrialCaroline M Moore, Nicola L Robertson, Fatima Jichi, et al.
European Urology Oncology|August 15, 2019
A Multicentre Analysis of the Detection of Clinically Significant Prostate Cancer Following Transperineal Image-fusion Targeted and Nontargeted Systematic Prostate Biopsy in Men at RiskSaiful Miah, Feargus Hosking-Jervis, Martin J Connor, et al.
Journal of Medical Economics|September 1, 2023
Focal therapy versus radical prostatectomy and external beam radiotherapy as primary treatment options for non-metastatic prostate cancer: results of a cost-effectiveness analysisDeepika Reddy, Marieke van Son, Max Peters, et al.
The Prostate|August 4, 2018
Immunohistochemical biomarker validation in highly selective needle biopsy microarrays derived from mpMRI-characterized prostatesJonathan Olivier, Vasilis Stavrinides, Jonathan Kay, et al.
BMC Medical Imaging|November 16, 2019
Localising occult prostate cancer metastasis with advanced imaging techniques (LOCATE trial): a prospective cohort, observational diagnostic accuracy trial investigating whole-body magnetic resonance imaging in radio-recurrent prostate cancerSola Adeleke, Arash Latifoltojar, Harbir Sidhu, et al.
The Journal of Urology|April 4, 2023
Evaluation of Outcomes Following Focal Ablative Therapy for Treatment of Localized Clinically Significant Prostate Cancer in Patients >70 Years: A Multi-institute, Multi-energy 15-Year ExperienceDavid Habashy, Deepika Reddy, Max Peters, et al.
Prostate Cancer and Prostatic Diseases|May 2, 2021
Conventional radical versus focal treatment for localised prostate cancer: a propensity score weighted comparison of 6-year tumour controlMarieke J van Son, Max Peters, Deepika Reddy, et al.
Pageof 13